FRE
Click for more information
0.00% 6.0¢ firebrick pharma limited

All interested shareholders should review this presentation, as...

  1. FirebrickPharma
    75 Posts.
    lightbulb Created with Sketch. 75
    clock Created with Sketch.
    24/11/22
    12:55
    Post #: 64964208
    All interested shareholders should review this presentation, as it details our plans for 2023 and introduces our US/EU partnering strategy, which we hope to see turn into at least one major licensing deal in 2023.
    We also present some interesting viral data from those subjects so far recruited into the common cold Phase 3 trial.
    If you have any questions on anything in the presentation, just post them here and I'll respond where appropriate.
    Peter M
    FRE Price at posting: 28.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply
 

Featured News

CCO Calmer Co taps investors for $2M
right-arrow Created with Sketch.
HZR Hazer Group and POSCO team up to look at low carbon steel
right-arrow Created with Sketch.
IMM Immutep targets $100m for lung cancer drug trial tests
right-arrow Created with Sketch.
AVH FDA greenlights Avita's RECELL GO skin transplant cell harvesting device
right-arrow Created with Sketch.
SPA Spacetalk makes European Market Reentry with Elisa
right-arrow Created with Sketch.
TLG Talga shows expansion options for Sweden's Vittangi graphite project
right-arrow Created with Sketch.

Top Stories

watchlist Created with Sketch. Add FRE (ASX) to my watchlist
(20min delay)
Last
6.0¢ 		Change
0.000(0.00%) 		Mkt cap ! $11.71M
Open High Low Value Volume
6.0¢ 6.0¢ 6.0¢ $1.2K 20K

Buyers (Bids)

No. Vol. Price($)
1 97041 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
6.6¢ 80477 2
View Market Depth
Last trade - 10.02am 05/06/2024 (20 minute delay) ?
FRE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.